[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100558048":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":18,"centralContacts":19,"locations":18,"responsibleParty":26,"collaborators":18,"id":28,"slug":29,"hasResults":30,"nctId":31,"briefTitle":32,"officialTitle":33,"acronym":18,"eligibilityCriteria":34,"healthyVolunteers":30,"sex":35,"minAge":36,"maxAge":18,"enrollmentInfo":37,"targetDuration":18,"studyType":40,"phases":41,"briefSummary":43,"conditions":44,"keywords":51,"overallStatus":58,"whyStopped":18,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":18},{"fullName":5,"class":6},"Mezoo Co., Ltd.","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"ECG monitoring by telemetry device and patch-type ECG monitor at the same time","EXPERIMENTAL","The patient undergoes electrocardiogram monitoring simultaneously through a telemetry device and a patch-type electrocardiograph.",[13],"Device: ECG monitoring by telemetry device and patch-type ECG monitor at the same time",[15],{"type":16,"name":9,"description":11,"armGroupLabels":17,"otherNames":18},"DEVICE",[9],null,[20],{"name":21,"role":22,"phone":23,"phoneExt":24,"email":25},"SH Lee","CONTACT","82-33-761-2006","412","shlee@me-zoo.com",{"type":27,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR","100558048","analysis-of-the-efficacy-and-stability-of-a-wearable-ecg-monitor-100558048",false,"NCT06546046","Analysis of the Efficacy and Stability of a Wearable ECG Monitor","Analysis of the Efficacy and Stability of a Single-Channel Patch-Type Wearable Electrocardiogram Monitor","Inclusion Criteria:\n\n1. Adults aged 19 years or older\n2. Patients admitted to Chonnam National University Hospital who require ECG monitoring\n3. Individuals who have expressed their intention to participate in this study or have obtained written consent from a proxy\n\nExclusion Criteria:\n\n1. Individuals who are unable to provide consent themselves or through a legally designated representative\n2. Individuals deemed unsuitable for participation in the clinical trial based on the researcher's judgment","ALL","19 Years",{"count":38,"type":39},100,"ESTIMATED","INTERVENTIONAL",[42],"NA","This study aims to analyze the efficacy and safety of wearable electrocardiogram (ECG) monitoring by simultaneously attaching a single-channel patch-type wearable ECG monitoring device (HiCardi+ by Mezoo Co., Ltd.) and a telemetry device (IntelliVue MX40 by Philips) used in actual wards to patients prescribed with ECG monitoring",[45,46,47,48,49,50],"Arrhythmias, Cardiac","Bradycardia","Tachycardia","Atrial Fibrillation","Atrial Flutter","Ventricular Premature Complexes",[52,53,54,55,56,57],"Monitoring","Telemetry","Wearable device","Arrhythmia alarm","Signal loss","Satisfaction survey","NOT_YET_RECRUITING","2024-08-11",{"date":61,"type":62},"2024-08-14","ACTUAL",{"date":64,"type":39},"2024-09-09",{"date":66,"type":39},"2025-03-30",{"name":5,"class":6}]